Synthesis and biological activity of a potent dual-acting platelet-activating factor and 5-lipoxygenase inhibitor.

被引：0

作者：

Hussoin, MS ^{[1
]}

Biftu, T ^{[1
]}

Cai, X ^{[1
]}

Scannell, RT ^{[1
]}

Grewal, G ^{[1
]}

Young, M ^{[1
]}

Yaeger, D ^{[1
]}

Killian, DB ^{[1
]}

Wypij, D ^{[1
]}

Lobell, R ^{[1
]}

Eckman, J ^{[1
]}

LibertineGraham, L ^{[1
]}

Qian, CG ^{[1
]}

Yeh, CG ^{[1
]}

机构：

[1] CYTOMED INC,CAMBRIDGE,MA 02139

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1996年 / 211卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：205 / MEDI

页数：1

共 50 条

[31] Discovery of ucb 35440: A potent and orally active dual acting 5-lipoxygenase inhibitor and H1 receptor antagonist.
Cai, X
Arrington, M
Bayless, L
Eckman, J
Eckert, M
Ene, D
Ellis, J
Hussoin, S
Latham, M
Lewis, T
Libertine, L
Nicolas, JM
Scannell, R
Selig, W
Schwartz, E
Wels, B
Wypij, D
Young, M
Zou, D
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U62 - U62
[32] SYNTHESIS AND BIOLOGICAL-ACTIVITY OF SOME STRUCTURAL ANALOGS OF PLATELET-ACTIVATING FACTOR (PAF-ACETHER)
TENCE, M
MICHEL, E
COEFFIER, E
POLONSKY, J
GODFROID, JJ
BENVENISTE, J
AGENTS AND ACTIONS, 1981, 11 (6-7): : 558 - 559
[33] Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF)
Merlos, M
Giral, M
Balsa, D
Ferrando, R
Queralt, M
Puigdemont, A
GarciaRafanell, J
Forn, J
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 280 (01): : 114 - 121
[34] Approach to dual-acting platelet activating factor (PAF) receptor antagonist/thromboxane synthase inhibitor (TxSI) based on the link of PAF antagonists and TxSIs
Fujita, M
Seki, T
Inada, H
Shimizu, K
Takahama, A
Sano, T
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (03) : 341 - 344
[35] EFFECTS OF REV-5901, A 5-LIPOXYGENASE INHIBITOR AND LEUKOTRIENE ANTAGONIST, ON PULMONARY RESPONSES TO PLATELET ACTIVATING FACTOR IN THE GUINEA-PIG
ANDERSON, G
FENNESSY, M
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 94 (04) : 1115 - 1122
[36] TEPOXALIN - A DUAL CYCLOOXYGENASE 5-LIPOXYGENASE INHIBITOR OF ARACHIDONIC-ACID METABOLISM WITH POTENT ANTIINFLAMMATORY ACTIVITY AND A FAVORABLE GASTROINTESTINAL PROFILE
ARGENTIERI, DC
RITCHIE, DM
FERRO, MP
KIRCHNER, T
WACHTER, MP
ANDERSON, DW
ROSENTHALE, ME
CAPETOLA, RJ
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 271 (03): : 1399 - 1408
[37] SYNTHESIS AND DEVELOPMENT OF L-670,630 AS A POTENT AND ORALLY ACTIVE INHIBITOR OF 5-LIPOXYGENASE
THERIEN, M
LAU, CK
BELANGER, PC
DUFRESNE, C
SCHEIGETZ, J
FITZSIMMONS, B
RIENDEAU, D
DENIS, D
GUAY, J
CHARLESON, S
PIECHUTA, H
MCFARLANE, CS
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1991, 202 : 180 - MEDI
[38] Design, Synthesis and Cellular Characterization of a Dual Inhibitor of 5-Lipoxygenase and Soluble Epoxide Hydrolase
Meirer, Karin
Glatzel, Daniel
Kretschmer, Simon
Wittmann, Sandra K.
Hartmann, Markus
Bloecher, Rene
Angioni, Carlo
Geisslinger, Gerd
Steinhilber, Dieter
Hofmann, Bettina
Fuerst, Robert
Proschak, Ewgenij
MOLECULES, 2017, 22 (01):
[39] MEDI 283-Synthesis and biological profile of substituted quinolines as potent 5-Lipoxygenase inhibitors
Gagnon, Marc
Brideau, Christine
Cauchon, Elizabeth
Chateauneuf, Anne
Ducharme, Yves
Frenette, Richard
Friesen, Richard W.
Guiral, Sebastien
Hamel, Pierre
Mancini, Joseph A.
Ouellet, Marc
Percival, David
Styhler, Angela
Wong, Elizabeth
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
[40] Indole derivatives as potent inhibitors of 5-lipoxygenase: Design, synthesis, biological evaluation, and molecular modeling
Zheng, Mingfang
Zheng, Mingyue
Ye, Deju
Deng, Yangmei
Qiu, Shuifeng
Luo, Xiaomin
Chen, Kaixian
Liu, Hong
Jiang, Hualiang
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (09) : 2414 - 2420

← 1 2 3 4 5 →